The College of Psychiatric and Neurologic Pharmacists (CPNP) membership has elected three officers to serve on the 2013-2015 Board of Directors. Assuming their offices effective July 1, 2013 will be Drs. Steven Burghart, Christopher Thomas, and Raymond Love.
Drs. Burghart, Thomas and Love join current and “retiring” board members:
PRESIDENT-ELECT
Steven Burghart, DPh, MBA, BCPP, Director of Pharmacy, Rolling Hills Hospital, Franklin, TN
Dr. Burghart joined CPNP in 2000 and has served in a number of volunteer roles for the association. He is currently serving his second year as Treasurer on the Board of Directors and as board liaison to the Consumer Relations Committee. Previously, he served as a member and Chair of the Consumer Relations Committee and member and Chair of the Membership Committee.
In addition to his CPNP service, Steve serves as Chair of the Specialty Council on Psychiatric Pharmacy with the Board of Pharmacy Specialties. He is in his fifth year of service on the council and will conclude his term on the council in 2013. He is a long time member of the American Society of Health System Pharmacists (ASHP) and was previously a member of the Kansas Society of Health System Pharmacists and the Kansas Pharmacists Association. Steve served for a number of years on the Board of the Kansas Pharmacists Association and was the 2003 recipient of the Harold N. Godwin Lecture award from the Kansas Society of Health System Pharmacists. Steve is also active in several volunteer activities at his church.
Steve has practiced in psychiatric pharmacy for more than 18 years, having received a pharmacy degree from the University of Kansas and a Masters in Business Administration from Baker University. He was board certified in psychiatric pharmacy in 1999 and re-certified in 2006. His previous psychiatric pharmacy positions include clinical pharmacist at Parkview Hospital, staff pharmacist and director at The Menninger Clinic and director of pharmacy at Prairie View, Inc. all in Kansas. His current position is director of pharmacy at Rolling Hills (psychiatric) Hospital in Franklin, Tennessee. His academic appointments include previously serving as Adjunct Clinical Assistant Professor at the University of Kansas and currently as an affiliate faculty at Belmont and Lipscomb Colleges of Pharmacy in Nashville.
TREASURER
Christopher Thomas, PharmD, BCPP, BCPS, CGP, Residency Program Director for PGY-1 and PGY-2 Psychiatry Specialty, Clinical Pharmacy Specialist in Psychiatry, Chillicothe Veterans Affairs Medical Center (VAMC), Clinical Assistant Professor of Pharmacology, Ohio University Heritage College of Osteopathic Medication, Chillicothe, OH
Dr. Thomas joined CPNP in 1999 as a pharmacy student. Chris currently serves as a member of the Program Committee and represents CPNP on the Pharmacy Quality Alliance for evaluating antipsychotic utilization in the long term care population. He has also served CPNP as the chairman of the American Society of Consultant Pharmacist Relationship Management Group (ASCP-RMG), and served several years on the Recertification and Resident Committees. He has been an author for the review/recertification course since 2006 covering both schizophrenia and elderly chapters during his tenure.
Chris has been in the field of psychiatric pharmacy for 13 years. He earned his Doctor of Pharmacy from Butler University in 2000 and completed a Psychiatric Pharmacy Residency at the Cleveland Veterans Affairs Medical Center (VAMC) in 2001. Upon completing residency training, he joined the Chillicothe VAMC, where he has grown his career for the past 12 years. He has served in various roles with a full scope of practice and prescribing privileges. Most of his clinical practice has been devoted to serving inpatients in the Mental Health Care Line, which comprises over 100 beds. He also works in an outpatient clinic providing care to the severely mental ill patients enrolled with the Mental Health Intensive Care Management (MHICM) team.
He has always had a passion for teaching, and has worked to transform the Chillicothe VAMC into a solid, quality academic teaching facility, especially within the field of psychiatry. In realizing and forecasting the increasing demand for PGY-1 Pharmacy Practice Residencies, he implemented a PGY-1 program at the Chillicothe VAMC that became ASHP accredited in 2007. Shortly after the PGY-1 program became accredited, he began work on creating the PGY-2 Psychiatric Pharmacy Residency Program. The PGY-2 psychiatric pharmacy program received full accreditation from ASHP in 2012. In addition to the pharmacy residency programs, he also worked closely in the development of the Doctor of Osteopathic Medicine Psychiatry Residency Program that is a joint venture between the Chillicothe VAMC and Grandville Medical Center. This program is currently in the third year and received full accreditation in 2012. In addition to post graduate education, Chris precepts students from several colleges of pharmacy throughout the Midwest and lectures in the CNS therapeutics course at the University of Cincinnati James L. Winkle College of Pharmacy.
MEMBER-AT-LARGE
Raymond Love, PharmD, BCPP, FASHP, Professor and Director, Mental Health Program, University of Maryland School of Pharmacy, Clinical Associate Professor, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD
Dr. Love is a founding member of CPNP and one of the committee chairs of the original Board of Pharmacy Specialties petition for recognition of Psychiatric Pharmacists. Ray has a long history with CPNP and in the promotion of psychiatric pharmacy practice. His service to CPNP ranges from service on the Reimbursement Task Force, Entrepreneurship Committee and Legislative Committee to serving as liaison to the Pharmacists Provider Coalition, Leadership for Medication Management and the Pharmacy Health Care Reform Stakeholder Coalition. In these liaison positions, he played a part in assuring that Medication Therapy Management was included in the Affordable Care Act.
Ray earned a Doctor of Pharmacy degree from the University of Maryland School of Pharmacy in 1977. He has served as a psychiatric clinical pharmacist, area health education director (AHEC) director, residency director, director of pharmacy, state mental health pharmacy program director and associate dean. His experiences have included both inpatient and outpatient psychiatric practice in rural as well as urban settings. Along the way, he established the first ASHP accredited residency clinical residency at the University of Maryland School of Pharmacy, one of the first statewide clozapine monitoring programs, a statewide program to address antipsychotic use in children and the University’s Mental Health Pharmacy Program which furnishes services to five state psychiatric hospitals and Maryland Medicaid. He served as a member of the Maryland Board of Pharmacy where he helped establish pharmacist delivered collaborative drug therapy management in Maryland. In 2010, he was the recipient of the CPNP Saklad Memorial Award.
In addition to his faculty duties, he directs the Mental Health Pharmacy Program which includes 30 pharmacists in psychiatric practice throughout Maryland. In addition, he also directs the Maryland Peer Review for Mental Health Drugs in Children and Adolescents Program, a cooperative program between Maryland Medicaid, the University of Maryland School of Pharmacy and Department of Psychiatry and the Maryland Psychiatric Research Center. He represents the American Pharmacists Association on the Pharmacy Quality Alliance Mental Health Workgroup and has represented psychiatric pharmacy on panels and workgroups for the National Quality Forum, and the United States Pharmacopeia and National Institutes of Health. He also serves as one of two advisors for the University of Maryland CPNP Student Chapter.
About CPNP
The College of Psychiatric and Neurologic Pharmacists (CPNP) is a professional association of over 1100 members dedicated to promoting excellence in pharmacy practice, education and research to optimize treatment outcomes of individuals affected by psychiatric and neurologic disorders. Members of CPNP are generally pharmacists who work directly with patients and caregivers to apply specialized clinical knowledge and skills, educate and train healthcare professionals and develop new knowledge in order to improve health outcomes for those individuals with psychiatric and neurologic disorders. Members apply evidence-based, cost-efficient best practices as a member of a treatment team to achieve patient recovery and improved quality of life.
CPNP actively partners with the National Alliance on Mental Illness (NAMI) and health care associations recognizing the importance of consumers, pharmacists and other specialized professionals working together in managing psychiatric illness. CPNP is integrally involved in supporting and providing educational products and services such as the CPNP Annual Meeting and recertification education for the 647 Board Certified Psychiatric Pharmacists (BCPPs), 70% of whom are members of CPNP.